Dhaval Patel, Executive Vice President and Chief Scientific Officer at UCBDhaval Patel, Executive Vice President and Chief Scientific Officer at UCB

Brussles, Belgium — UCB said Wednesday it successfully completed a EUR 500 million senior unsecured bond issue with a 4.25% coupon and 6-year tenor.

The funds will be used for general corporate purposes, including refinancing debt from an acquisition.

The bonds were placed with institutional investors and will be listed on Euronext Brussels.

UCB’s Psoriasis Treatment BIMZELX Shows “Encouraging” Results in 4-Yr Study

By Lisa Luckas

Lisa Luckas is a Sr. Business News Editor at Nobot.News.

Leave a Reply

Your email address will not be published. Required fields are marked *

GDPR Cookie Consent with Real Cookie Banner